LR Kelland

2.0k total citations
37 papers, 1.7k citations indexed

About

LR Kelland is a scholar working on Oncology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, LR Kelland has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 17 papers in Molecular Biology and 10 papers in Organic Chemistry. Recurrent topics in LR Kelland's work include Metal complexes synthesis and properties (14 papers), Ferrocene Chemistry and Applications (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). LR Kelland is often cited by papers focused on Metal complexes synthesis and properties (14 papers), Ferrocene Chemistry and Applications (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). LR Kelland collaborates with scholars based in United Kingdom, Netherlands and United States. LR Kelland's co-authors include Paul Rogers, Swee Y. Sharp, Paul Workman, Timothy G. Myers, KR Harrap, Nicholas P. Farrell, John D. Roberts, Kenneth R. Harrap, G Abel and Prakash Mistry and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

LR Kelland

36 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
LR Kelland United Kingdom 21 927 843 425 143 141 37 1.7k
Paolo Lunghi Italy 27 1.0k 1.1× 1.1k 1.3× 653 1.5× 118 0.8× 182 1.3× 45 2.2k
Michael Frezza United States 14 1.0k 1.1× 847 1.0× 640 1.5× 148 1.0× 119 0.8× 15 1.9k
Sara M. Schmitt United States 14 834 0.9× 1.0k 1.2× 451 1.1× 120 0.8× 168 1.2× 20 1.9k
Ichiro Okamoto Austria 21 544 0.6× 730 0.9× 345 0.8× 113 0.8× 112 0.8× 44 1.9k
Nouri Neamati United States 26 923 1.0× 1.1k 1.3× 635 1.5× 99 0.7× 174 1.2× 50 2.5k
Melanie Valenti United Kingdom 30 1.1k 1.1× 1.7k 2.0× 383 0.9× 109 0.8× 302 2.1× 61 2.6k
Wilson B. Knight United States 23 770 0.8× 1.0k 1.2× 319 0.8× 124 0.9× 147 1.0× 46 1.9k
Peter M. Bruno United States 19 816 0.9× 847 1.0× 453 1.1× 158 1.1× 138 1.0× 25 1.7k
M. V. Ramana Reddy United States 23 488 0.5× 933 1.1× 733 1.7× 76 0.5× 109 0.8× 80 2.1k
Lee D. Arnold United States 18 540 0.6× 1.1k 1.4× 493 1.2× 63 0.4× 168 1.2× 37 1.9k

Countries citing papers authored by LR Kelland

Since Specialization
Citations

This map shows the geographic impact of LR Kelland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by LR Kelland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites LR Kelland more than expected).

Fields of papers citing papers by LR Kelland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by LR Kelland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by LR Kelland. The network helps show where LR Kelland may publish in the future.

Co-authorship network of co-authors of LR Kelland

This figure shows the co-authorship network connecting the top 25 collaborators of LR Kelland. A scholar is included among the top collaborators of LR Kelland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with LR Kelland. LR Kelland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kelland, LR. (2004). “Of mice and men”. European Journal of Cancer. 40(6). 827–836. 263 indexed citations
2.
Tiffin, Nicki, et al.. (2001). In vitro prevention of the emergence of multidrug resistance in a pediatric rhabdomyosarcoma cell line.. PubMed. 7(10). 3193–8. 27 indexed citations
3.
Beale, Philip, Paul Rogers, Frances Boxall, Swee Y. Sharp, & LR Kelland. (2000). BCL-2 family protein expression and platinum drug resistance in ovarian carcinoma. British Journal of Cancer. 82(2). 436–440. 93 indexed citations
4.
Vizcaya‐Ruíz, Andrea De, Adolfo Rivero‐Müller, Lena Ruíz-Azuara, et al.. (2000). Induction of apoptosis by a novel copper-based anticancer compound, Casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells. Toxicology in Vitro. 14(1). 1–5. 123 indexed citations
5.
O'Neill, CF, Beate Köberle, John R. Masters, & LR Kelland. (1999). Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin. British Journal of Cancer. 81(8). 1294–1303. 35 indexed citations
6.
Kelland, LR, Swee Y. Sharp, Paul Rogers, Timothy G. Myers, & Paul Workman. (1999). DT-Diaphorase Expression and Tumor Cell Sensitivity to 17-Allylamino,17-demethoxygeldanamycin, an Inhibitor of Heat Shock Protein 90. JNCI Journal of the National Cancer Institute. 91(22). 1940–1949. 280 indexed citations
7.
Bradshaw, Tracey D., Dashuang Shi, Robert Schultz, et al.. (1998). Influence of 2-(4-aminophenyl)benzothiazoles on growth of human ovarian carcinoma cells in vitro and in vivo. British Journal of Cancer. 78(4). 421–429. 62 indexed citations
8.
9.
Lee, Moses, et al.. (1996). Novel platinum(II) derivatives of analogues of netropsin and distamycin: Synthesis, DNA binding and cytotoxic properties. Medicinal Chemistry Research. 6(6). 365–371. 11 indexed citations
10.
Raynaud, Florence I., et al.. (1996). Intracellular metabolism of the orally active platinum drug JM216: influence of glutathione levels. British Journal of Cancer. 74(3). 380–386. 35 indexed citations
11.
O'Neill, CF, et al.. (1996). Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine)dihydroxodichloroplatinum(IV) complex. British Journal of Cancer. 74(7). 1037–1045. 26 indexed citations
12.
Jackman, A.L., et al.. (1995). Molecular characterisation of two cell lines selected for resistance to the folate-based thymidylate synthase inhibitor, ZD1694. British Journal of Cancer. 71(5). 925–930. 33 indexed citations
13.
Uchegbu, Ijeoma F., et al.. (1993). THE ACTIVITY OF DOXORUBICIN NIOSOMES AGAINST A RESISTANT HUMAN OVARIAN CANCER CELL LINE. UCL Discovery (University College London). 2 indexed citations
14.
Kelland, LR, et al.. (1993). ANTITUMOR-ACTIVITY OF ORALLY-ADMINISTERED AMMINE AMINE PLATINUM (IV) DICARBOXYLATE COMPLEXES AGAINST A PANEL OF HUMAN OVARIAN-CARCINOMA XENOGRAFTS. International Journal of Oncology. 2(6). 1043–8. 5 indexed citations
15.
Jones, Mark, J Siracký, LR Kelland, & KR Harrap. (1993). Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts. British Journal of Cancer. 67(1). 24–29. 21 indexed citations
16.
17.
18.
Kelland, LR, et al.. (1988). Chemotherapy-radiation interactions in human cervix carcinoma xenografts. British Journal of Cancer. 58(6). 738–741. 18 indexed citations
19.
Kelland, LR, et al.. (1988). Inhibition of radiation dose-rate-sparing effects in human tumor cells by 3-aminobenzamide.. PubMed. 167–71. 4 indexed citations
20.
Kelland, LR & Lynne Bingle. (1988). Radiosensitivity and characterisation of a newly established cell line from an epithelioid sarcoma. British Journal of Cancer. 58(3). 322–325. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Lunghi Breakdown of academic impact, for papers by Michael Frezza Breakdown of academic impact, for papers by Sara M. Schmitt Breakdown of academic impact, for papers by Ichiro Okamoto Breakdown of academic impact, for papers by Nouri Neamati Breakdown of academic impact, for papers by Melanie Valenti Breakdown of academic impact, for papers by Wilson B. Knight Breakdown of academic impact, for papers by Peter M. Bruno Breakdown of academic impact, for papers by M. V. Ramana Reddy Breakdown of academic impact, for papers by Lee D. Arnold
Rankless by CCL
2026